Reports Q3 revenue $318.1M, consensus $300.49M. “LivaNova (LIVN) delivered strong revenue and operating income growth in the Q3,” said Vladimir Makatsaria, CEO of LivaNova. “This performance reflects the strength of our team’s ongoing execution and steadfast commitment to serving customers and their patients. We look forward to building on this momentum in the Q4 and in 2025, driven by our continued focus on performance, innovation, and talent.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.